Cyclo Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Cyclo Therapeutics (CYTH) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Cyclo Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cyclo Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cyclo Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $153 | 194 | 0.79 |
| 2024-06-30 | $194 | 153 | 1.27 |
| 2024-03-31 | $213 | 153 | 1.39 |
| 2023-12-31 | $28 | 18 | 1.61 |
| 2023-09-30 | $342 | 240 | 1.43 |